Browse
Register
Log In
Variables
4291 variables.
Search variables
---------
Activity tracker (CHRIS follow-up) (md_x1_0139)
Administrative data (CHRIS baseline) (md_x0_0022)
Administrative data (CHRIS follow-up) (md_x1_0022)
Affinity-based plasma proteomics (CHRIS baseline) (md_x0_0103)
Affinity-based plasma proteomics (Upcoming, CHRIS baseline) (md_up_0011)
Alcohol (CHRIS baseline) (md_x0_0037)
Alcohol (CHRIS follow-up) (md_x1_0037)
Anthropometry (CHRIS baseline) (md_x0_0012)
Anthropometry (CHRIS follow-up) (md_x1_0012)
Anthropometry form (CHRIS follow-up) (md_x1_0135)
Anxiety (CHRIS baseline) (md_x0_0098)
Anxiety (CHRIS follow-up) (md_x1_0098)
Arthritis (CHRIS follow-up) (md_x1_0130)
Autonomic system (CHRIS baseline) (md_x0_0089)
Autonomic system (CHRIS follow-up) (md_x1_0089)
Baseline information (CHRIS COVID-19) (md_cc_0002)
Biochemical traits (CHRIS COVID-19) (md_cc_0003)
Biochemical traits (CHRIS baseline) (md_x0_0002)
Biochemical traits (CHRIS follow-up) (md_x1_0002)
Birth (CHRIS baseline) (md_x0_0038)
Blood (CHRIS COVID-19) (ms_cc_0002)
Blood (CHRIS NAFLD) (ms_na_0002)
Blood (CHRIS PAREGEN1) (ms_p1_0002)
Blood (CHRIS PAREGEN2) (ms_p2_0002)
Blood (CHRIS baseline) (ms_x0_0002)
Blood (CHRIS follow-up) (ms_x1_0002)
Blood collection form (CHRIS baseline) (md_x0_0007)
Blood collection form (CHRIS follow-up) (md_x1_0007)
Blood drawing pain rating (CHRIS follow-up) (md_x1_0134)
Blood measurements (CHRIS baseline) (md_x0_0009)
Blood measurements (CHRIS follow-up) (md_x1_0009)
Blood pressure (CHRIS baseline) (md_x0_0013)
Blood pressure (CHRIS follow-up) (md_x1_0013)
Blood values (CHRIS baseline) (md_x0_0039)
Blood values (CHRIS follow-up) (md_x1_0039)
CHRIS COVID-19 data (md_cc_0001)
CHRIS COVID-19 samples (ms_cc_0001)
CHRIS NAFLD data (md_na_0001)
CHRIS NAFLD samples (ms_na_0001)
CHRIS PAREGEN1 data (md_p1_0001)
CHRIS PAREGEN1 samples (ms_p1_0001)
CHRIS PAREGEN2 data (md_p2_0001)
CHRIS PAREGEN2 samples (ms_p2_0001)
CHRIS baseline data (md_x0_0001)
CHRIS baseline samples (ms_x0_0001)
CHRIS data (md_x_0001)
CHRIS follow-up data (md_x1_0001)
CHRIS follow-up data (Upcoming CHRIS follow-up) (md_up_0010)
CHRIS follow-up samples (ms_x1_0001)
CHRIS samples (ms_x_0001)
CHRIS sub-study data (md_xs_0001)
CHRIS sub-study samples (ms_xs_0001)
COVID-19 infection (CHRIS follow-up) (md_x1_0123)
COVID-19 vaccination (CHRIS follow-up) (md_x1_0117)
Cancer (CHRIS baseline) (md_x0_0040)
Cancer (CHRIS follow-up) (md_x1_0040)
Cardiac arrhythmias (CHRIS baseline) (md_x0_0041)
Cardiac arrhythmias (CHRIS follow-up) (md_x1_0041)
Cardiovascular diseases (CHRIS baseline) (md_x0_0042)
Cardiovascular diseases (CHRIS baseline) (md_x0_0107)
Cardiovascular traits (CHRIS baseline) (md_x0_0114)
Cardiovascular traits (CHRIS follow-up) (md_x1_0114)
Childhood trauma (CHRIS baseline) (md_x0_0081)
Chronic diseases (CHRIS baseline) (md_x0_0043)
Chronic diseases (CHRIS follow-up) (md_x1_0043)
Chronic pain (CHRIS baseline) (md_x0_0044)
Chronic pain (CHRIS follow-up) (md_x1_0124)
Chronotype (CHRIS baseline) (md_x0_0091)
Circulation (CHRIS baseline) (md_x0_0045)
Circulation (CHRIS follow-up) (md_x1_0045)
Clinical traits (CHRIS baseline) (md_x0_0011)
Clinical traits (CHRIS follow-up) (md_x1_0011)
Cognition (CHRIS baseline) (md_x0_0070)
Complement system (CHRIS baseline) (md_x0_0004)
Complement system, additional batch (Upcoming, CHRIS baseline) (md_up_0009)
Continuous blood pressure measurement (CHRIS baseline) (md_x0_0118)
Corticosteroids (Upcoming, CHRIS baseline) (md_up_0008)
Cumulative Illness Rating Scale (CHRIS baseline) (md_x0_0115)
Data-derived traits (CHRIS baseline) (md_x0_0106)
Data-derived traits (CHRIS follow-up) (md_x1_0106)
Day summary (md_x1_0140)
Demographic data (CHRIS baseline) (md_x0_0024)
Demographic data (CHRIS follow-up) (md_x1_0024)
Depression (CHRIS baseline) (md_x0_0090)
Depression (CHRIS follow-up) (md_x1_0090)
Depression and mania (CHRIS baseline) (md_x0_0085)
Derived traits (CHRIS baseline) (md_x0_0104)
Derived traits (CHRIS follow-up) (md_x1_0104)
Diabetes (CHRIS baseline) (md_x0_0046)
Diabetes (CHRIS follow-up) (md_x1_0046)
Drug intake (CHRIS baseline) (md_x0_0018)
Drug intake (CHRIS follow-up) (md_x1_0018)
Drugs complete dataset (CHRIS follow-up) (md_x1_0019)
Drugs summary (CHRIS baseline) (md_x0_0020)
Drugs summary (CHRIS follow-up) (md_x1_0020)
Dynamic consent survey (CHRIS baseline) (md_x0_0109)
ECG 10s (CHRIS baseline) (md_x0_0015)
ECG 10s (CHRIS follow-up) (md_x1_0015)
ECG 20m (CHRIS baseline) (md_x0_0016)
ECG representations based on 32 generative factors (Upcoming, CHRIS baseline) (md_up_0015)
Early repolarization pattern (CHRIS baseline) (md_x0_0116)
Exposure (CHRIS baseline) (md_x0_0047)
Feces (CHRIS NAFLD) (ms_na_0005)
Flavonoid intake (CHRIS baseline) (md_x0_0078)
Flavonoid intake (CHRIS follow-up) (md_x1_0078)
Food frequency questionnaire (CHRIS baseline) (md_x0_0077)
Food frequency questionnaire (CHRIS follow-up) (md_x1_0077)
General health (CHRIS follow-up) (md_x1_0128)
General information (CHRIS COVID-19) (md_cc_0004)
General information (CHRIS baseline) (md_x0_0021)
General information (CHRIS follow-up) (md_x1_0021)
Genomic variants (CHRIS baseline) (md_x0_0026)
Genomics (CHRIS baseline) (md_x0_0025)
Genotype array (CHRIS baseline) (md_x0_0028)
Gynecology (CHRIS baseline) (md_x0_0048)
Gynecology (CHRIS follow-up) (md_x1_0048)
Handedness (CHRIS follow-up) (md_x1_0136)
Heart failure (CHRIS baseline) (md_x0_0049)
Heart failure (CHRIS follow-up) (md_x1_0049)
Heart rate variability (CHRIS baseline) (md_x0_0113)
Heart rate variability, cardiologist curated (CHRIS baseline) (md_x0_0112)
Hypertension (CHRIS follow-up) (md_x1_0116)
Hypomania (CHRIS baseline) (md_x0_0082)
Illness rating (CHRIS follow-up) (md_x1_0129)
Infectious diseases (CHRIS follow-up) (md_x1_0122)
Informed consent (CHRIS follow-up) (md_x1_0110)
Informed consent (CHRIS baseline) (md_x0_0110)
Insomnia (CHRIS follow-up) (md_x1_0121)
Interpretation (CHRIS follow-up) (md_x1_0133)
Interview (CHRIS baseline) (md_x0_0036)
Interview (CHRIS follow-up) (md_x1_0036)
Iron metabolism (CHRIS baseline) (md_x0_0005)
Iron metabolism (Upcoming, CHRIS baseline) (md_up_0003)
Kidney diseases (CHRIS baseline) (md_x0_0050)
Kidney diseases (CHRIS follow-up) (md_x1_0050)
Lab routine measurements (CHRIS baseline) (md_x0_0008)
Lab routine measurements (CHRIS follow-up) (md_x1_0008)
Longitudinal information (CHRIS COVID-19) (md_cc_0005)
MICROS data (md_mi_0001)
MICROS samples (ms_mi_0001)
Major psychiatric diagnoses (CHRIS baseline) (md_x0_0084)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS COVID 19) (md_up_0014)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS baseline, CHRIS NAFLD) (md_up_0007)
Mass-spectrometry plasma proteomics: peptides (CHRIS NAFLD) (md_na_0101)
Mass-spectrometry plasma proteomics: peptides (CHRIS baseline) (md_x0_0101)
Mass-spectrometry plasma proteomics: proteins (CHRIS NAFLD) (md_na_0102)
Mass-spectrometry plasma proteomics: proteins (CHRIS baseline) (md_x0_0102)
Metabolomics (CHRIS NAFLD) (md_na_0063)
Metabolomics (CHRIS baseline) (md_x0_0063)
Metagenomes from saliva and feces (Upcoming, CHRIS NAFLD) (md_up_0016)
Migraine (CHRIS baseline) (md_x0_0051)
Mitochondrial DNA (Upcoming, CHRIS baseline) (md_up_0019)
Mitochondrial DNA copy number (CHRIS baseline) (md_x0_0006)
Movement disorder examination (CHRIS baseline) (md_x0_0111)
Myocardial infarction (CHRIS baseline) (md_x0_0052)
Myocardial infarction (CHRIS follow-up) (md_x1_0052)
NAFLD sub-study data (Upcoming CHRIS NAFLD) (md_up_0006)
NOT IN USE (md_x_0003)
NOT IN USE md_x0_0033 (md_x0_0033)
NOT IN USE md_x0_0034 (md_x0_0034)
NOT IN USE md_x0_0122 (md_x0_0122)
NOT IN USE md_x0_0123 (md_x0_0123)
NOT IN USE md_x0_0124 (md_x0_0124)
NOT IN USE md_x0_0125 (md_x0_0125)
NOT IN USE ms_x0_0005 (ms_x0_0005)
NOT IN USE ms_x0_0006 (ms_x0_0006)
NOT IN USE ms_x0_0007 (ms_x0_0007)
NOT IN USE ms_x0_0008 (ms_x0_0008)
NOT IN USE ms_x0_0009 (ms_x0_0009)
NOT IN USE ms_x0_0010 (ms_x0_0010)
NOT IN USE ms_x0_0011 (ms_x0_0011)
NOT IN USE test (test)
NOT IN USE upcoming_0001 (upcoming_0001)
NOT IN USE upcoming_0002 (upcoming_0002)
NOT IN USE upcoming_0003 (upcoming_0003)
NOT IN USE upcoming_0004 (upcoming_0004)
Neurological phenotypes (CHRIS baseline) (md_x0_0108)
Neurological phenotypes (CHRIS follow-up) (md_x1_0108)
Neurological tests (CHRIS baseline) (md_x0_0068)
Neurological tests (CHRIS follow-up) (md_x1_0068)
Neurology (CHRIS baseline) (md_x0_0053)
Neurology (CHRIS follow-up) (md_x1_0053)
Neuropsychiatry questionnaire (CHRIS baseline) (md_x0_0080)
Neutralizing Antibody (CHRIS COVID-19) (md_cc_0006)
Notes (CHRIS follow-up) (md_x1_0138)
Nutrient intake (CHRIS baseline) (md_x0_0079)
Nutrient intake (CHRIS follow-up) (md_x1_0079)
Nutrition (CHRIS baseline) (md_x0_0054)
Occupation (CHRIS baseline) (md_x0_0055)
Occupation (CHRIS follow-up) (md_x1_0055)
Olfaction (CHRIS follow-up) (md_x1_0118)
Olfactory test (CHRIS baseline) (md_x0_0071)
Olfactory test (CHRIS follow-up) (md_x1_0071)
Optimism and pessimism (CHRIS baseline) (md_x0_0083)
Oral health (CHRIS baseline) (md_x0_0099)
Other diseases (CHRIS baseline) (md_x0_0056)
PAREGEN sub-study data (Upcoming, CHRIS PAREGEN) (md_up_0017)
PAREGEN2 sub-study data (Upcoming, CHRIS PAREGEN2) (md_up_0018)
Pain Sensitivity (CHRIS follow-up) (md_x1_0092)
Pain pressure threshold (CHRIS baseline) (md_x0_0069)
Pain sensitivity (CHRIS baseline) (md_x0_0092)
Pain sensitivity assessement (CHRIS follow-up) (md_x1_0119)
Pain staging (CHRIS follow-up) (md_x1_0125)
Parkinson screening (CHRIS baseline) (md_x0_0057)
Participant satisfaction survey (CHRIS follow-up) (md_x1_0132)
Participation information (CHRIS baseline) (md_x0_0023)
Participation information (CHRIS follow-up) (md_x1_0023)
Pedigree (CHRIS baseline) (md_x0_0074)
Person (CHRIS baseline) (md_x0_0058)
Person (CHRIS follow-up) (md_x1_0058)
Physical activity (CHRIS baseline) (md_x0_0093)
Physical activity (CHRIS follow-up) (md_x1_0093)
Proteomics (CHRIS NAFLD) (md_na_0100)
Proteomics (CHRIS baseline) (md_x0_0100)
Public imputation panels (CHRIS baseline) (md_x0_0027)
REM sleep (CHRIS baseline) (md_x0_0095)
REM sleep (CHRIS follow-up) (md_x1_0095)
Raw recordings ECG 10s (CHRIS baseline) (md_x0_0119)
Raw recordings ECG 20m (CHRIS baseline) (md_x0_0120)
Raw recordings spiralography (CHRIS baseline) (md_x0_0121)
Renin-angiotensin-aldosteron system (Upcoming, CHRIS baseline) (md_up_0005)
Resting ECG (CHRIS baseline) (md_x0_0014)
Resting ECG (CHRIS follow-up) (md_x1_0014)
Restless Legs Syndrome (CHRIS baseline) (md_x0_0096)
SARS-CoV-2 antibody (CHRIS follow-up) (md_x1_0115)
Saliva (CHRIS NAFLD) (ms_na_0004)
Saliva (CHRIS baseline) (ms_x0_0004)
Saliva microbiome (Upcoming, CHRIS baseline) (md_up_0013)
Sample-derived traits (CHRIS baseline) (md_x0_0105)
Sample-derived traits (CHRIS follow-up) (md_x1_0105)
Self-Assessement (CHRIS baseline) (md_x0_0076)
Self-Assessement (CHRIS follow-up) (md_x1_0076)
Self-Assessement at home (CHRIS follow-up) (md_x1_0127)
Self-reported ancestry (CHRIS baseline) (md_x0_0075)
Sleep behavior (CHRIS follow-up) (md_x1_0120)
Sleep quality (CHRIS baseline) (md_x0_0094)
Smoking (CHRIS baseline) (md_x0_0059)
Smoking (CHRIS follow-up) (md_x1_0059)
Socio-economic panel (CHRIS follow-up) (md_x1_0126)
Socio-economic panel, at home (CHRIS follow-up) (md_x1_0131)
Spiralography (CHRIS baseline) (md_x0_0072)
Stress perception (CHRIS baseline) (md_x0_0086)
Stroke (CHRIS baseline) (md_x0_0060)
Stroke (CHRIS follow-up) (md_x1_0060)
Summary (md_x1_0141)
Surgeries (CHRIS follow-up) (md_x1_0137)
TOPMed-imputed genotypes (CHRIS baseline) - NOT IN USE (md_x0_0030)
Targeted serum metabolomics (CHRIS NAFLD) (md_na_0065)
Targeted serum metabolomics (CHRIS baseline) (md_x0_0065)
Targeted serum metabolomics, expanded set (CHRIS baseline) (md_x0_0064)
Targeted serum metabolomics, expanded set (Upcoming, CHRIS baseline) (md_up_0004)
Temperament (CHRIS baseline) (md_x0_0087)
Thyroid diseases (CHRIS baseline) (md_x0_0061)
Thyroid diseases (CHRIS follow-up) (md_x1_0061)
Touchscreen (CHRIS baseline) (md_x0_0088)
Touchscreen (CHRIS follow-up) (md_x1_0088)
Untargeted serum metabolomics (Upcoming, CHRIS baseline) (md_up_0012)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS NAFLD) (md_na_0066)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS baseline) (md_x0_0066)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS NAFLD) (md_na_0067)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS baseline) (md_x0_0067)
Upcoming datasets (md_up_0001)
Urine (CHRIS NAFLD) (ms_na_0003)
Urine (CHRIS baseline) (ms_x0_0003)
Urine (CHRIS follow-up) (ms_x1_0003)
Urine measurements (CHRIS baseline) (md_x0_0010)
Urine measurements (CHRIS follow-up) (md_x1_0010)
Vaccination (CHRIS baseline) (md_x0_0062)
Vaccination status (CHRIS COVID-19) (md_cc_0007)
Whole-exome sequencing (CHRIS baseline) (md_x0_0029)
Whole-exome sequencing imputation (CHRIS baseline) (md_x0_0031)
Whole-exome sequencing raw data (CHRIS baseline) (md_x0_0032)
Without expected release date (md_up_0002)
Module
---------
Label
Character
Integer
Categorical
Float
Date
Time
Datetime
Boolean
Type
Search
Clear
Module
Label
Name
Description
Type
Drugs summary (CHRIS baseline)
x0dd44
Warfarin
Warfarin
Categorical
Drugs summary (CHRIS baseline)
x0dd24
Thyroid medication
Thyroid medication
Categorical
Drugs summary (CHRIS baseline)
x0dd40
Sex hormones
Sex hormones
Categorical
Drugs summary (CHRIS baseline)
x0dd38
Psycholeptics
Psycholeptics
Categorical
Drugs summary (CHRIS baseline)
x0dd39
Psychoanaleptics
Psychoanaleptics
Categorical
Drugs summary (CHRIS baseline)
x0dd26
Osteoporosis medication
Osteoporosis medication
Categorical
Drugs summary (CHRIS baseline)
x0dd23
Metabolic syndrome specific medication
Metabolic syndrome specific medication
Categorical
Drugs summary (CHRIS baseline)
x0dd22
Lipid modifying agents
Lipid modifying agents
Categorical
Drugs summary (CHRIS baseline)
x0dd42
Hypnotics and sedatives
Hypnotics and sedatives
Categorical
Drugs summary (CHRIS baseline)
x0dd01a
Drug usage
Drug usage
Categorical
Drugs summary (CHRIS baseline)
x0dd33
Digoxin
Digoxin
Categorical
Drugs summary (CHRIS baseline)
x0dd21
Diabetes medication
Diabetes medication
Categorical
Drugs summary (CHRIS baseline)
x0dd32
Class I and III antiarrhythmics
Class I and III antiarrhythmics
Categorical
Drugs summary (CHRIS baseline)
x0dd35
Cardiac therapy
Cardiac therapy
Categorical
Drugs summary (CHRIS baseline)
x0dd34
Calcium antagonist
Calcium antagonist
Categorical
Drugs summary (CHRIS baseline)
x0dd31
Beta blockers
Beta blockers
Categorical
Drugs summary (CHRIS baseline)
x0dd25
Asthma-COPD medication
Asthma-COPD medication
Categorical
Drugs summary (CHRIS baseline)
x0dd28
Arthritis medication
Arthritis medication
Categorical
Drugs summary (CHRIS baseline)
x0dd43
Antivertigo preparations
Antivertigo preparations
Categorical
Drugs summary (CHRIS baseline)
x0dd36
Antithrombotics
Antithrombotics
Categorical
Drugs summary (CHRIS baseline)
x0dd29
Antineoplastic and immunomodulating agents
Antineoplastic and immunomodulating agents
Categorical
Drugs summary (CHRIS baseline)
x0dd27
Antiglaucoma medication
Antiglaucoma medication
Categorical
Drugs summary (CHRIS baseline)
x0dd45
Antiepileptics
Antiepileptics
Categorical
Drugs summary (CHRIS baseline)
x0dd20
Anti-hypertensive medication
Anti-hypertensive medication
Categorical
Drugs summary (CHRIS baseline)
x0dd41
Anti-Parkinson drugs
Anti-Parkinson drugs
Categorical
Drugs summary (CHRIS baseline)
x0dd30
Angina medication
Angina medication
Categorical
Drugs summary (CHRIS baseline)
x0dd02a
Actual ACT drug usage
Actual ACT drug usage
Categorical
Drugs summary (CHRIS baseline)
x0dd37
Acid related disorders
Acid related disorders
Categorical
Drug intake (CHRIS baseline)
x0dd02
Type of drug
Type of drug
Categorical
Drug intake (CHRIS baseline)
x0dd12
Taking mode
Taking mode
Categorical
Drug intake (CHRIS baseline)
x0dd13
Taking frequency
Taking frequency (Taking Interval)
Categorical
Drug intake (CHRIS baseline)
x0dd15
Taken today
Taken today
Categorical
Drug intake (CHRIS baseline)
x0dd19
Study assistant
Study assistant
Categorical
Drug intake (CHRIS baseline)
x0dd09
Route of administration
Route of administration
Categorical
Drug intake (CHRIS baseline)
x0dd11
Prescribed by doctor
Drug prescribed by the doctor (Decreed)
Categorical
Drug intake (CHRIS baseline)
x0dd08
Pharmacological form
Pharmacological form (Pharma Form)
Character
Drug intake (CHRIS baseline)
x0dd16
Notes on data cleaning
Notes on data cleaning
Character
Drug intake (CHRIS baseline)
x0dd14
Duration of therapy
Length/duration of treatment/therapy (Taking Period)
Categorical
Drug intake (CHRIS baseline)
x0dd01
Drug usage
Binary indicator of drug usage
Categorical
Drug intake (CHRIS baseline)
x0dd17
Drug producer - original
Drug producer (Producer)
Character
Drug intake (CHRIS baseline)
x0dd10a
Drug dosage - elaborated
Drug dosage - elaborated
Character
Drug intake (CHRIS baseline)
x0dd07
Commercial drug name - original
Commercial drug name (Drug Name)
Character
Drug intake (CHRIS baseline)
x0dd18a
Comments by study assistant - elaborated
Comments by study assistants - elaborated
Character
Drug intake (CHRIS baseline)
x0dd03
Clean ATC code
Anatomical Therapeutic Chemical classification system (ATC) code
Character
Drug intake (CHRIS baseline)
x0dd06
Active compound
Active compound name (Drug)
Character
Drug intake (CHRIS baseline)
x0dd46
ATC rescued during QC
ATC rescued during data QC
Categorical
Drug intake (CHRIS baseline)
x0dd05
ATC 2nd level of classification
ATC 2nd level of classification - therapeutic subgroup
Character
Drug intake (CHRIS baseline)
x0dd04
ATC 1st level of classification
ATC 1st level of classification - anatomical main group
Categorical
Diabetes (CHRIS baseline)
x0dm02
Type of diabetes
Do you know which type of diabetes you have?
Categorical
Diabetes (CHRIS baseline)
x0dm04b
Insulin treatment (since)
Please, indicate the year since when you are treated with insulin. (age)
Integer
Diabetes (CHRIS baseline)
x0dmver
Diabetes version
Diabetes version
Categorical
Diabetes (CHRIS baseline)
x0dm03
Diabetes treatment
How are you treated?
Categorical
Diabetes (CHRIS baseline)
x0dmnote
Diabetes notes
Diabetes notes
Character
Diabetes (CHRIS baseline)
x0dm00
Diabetes (diagnosed)
Do you have diabetes mellitus?
Categorical
Diabetes (CHRIS baseline)
x0dm01b
Diabetes (age at diagnosis)
In which year was it diagnosed? (age at diagnosis)
Integer
Depression and mania (CHRIS baseline)
x0np32
Symptoms at least 4 days (y/n)
Did these symptoms last at least 4 days?
Categorical
Depression and mania (CHRIS baseline)
x0npver
MINI version
MINI version
Categorical
Depression and mania (CHRIS baseline)
x0np36
MINI Manic/hypomanic episode (past)
Manic/hypomanic episode (past) classification
Categorical
Depression and mania (CHRIS baseline)
x0np16
MINI Major depression episode (past)
Major depression episode (past) classification
Categorical
Depression and mania (CHRIS baseline)
x0np35
Duration (months)
How long did the longest hypomanic episode in your lifetime last?
Float
Depression and mania (CHRIS baseline)
x0np15
Duration (months)
How long did the longest depressive episode in your lifetime last?
Float
Depression and mania (CHRIS baseline)
x0np34
D6 - age at onset - mania
How old were you when your first hypomanic episode started?
Integer
Depression and mania (CHRIS baseline)
x0np33
D5 - frequency
How many episodes of hypomania did you have in your lifetime?
Integer
Depression and mania (CHRIS baseline)
x0np31
D4a - hospitalized (y/n)
Were you hospitalized for these problems?
Categorical
Depression and mania (CHRIS baseline)
x0np30
D4 - symptoms at least 1 week and social problems (y/n)
Did these symptoms last at least a week and cause significant problems at home, at work, socially, or at school?
Categorical
Depression and mania (CHRIS baseline)
x0np29
D3g - ignore risk/consequences
(During the times when you felt high, full of energy, or irritable did you:) Want so much to engage in pleasurable activities that you ignored the risks or consequences (for example, spending sprees, reckless driving, or sexual indiscretions)?
Categorical
Depression and mania (CHRIS baseline)
x0np28b
D3f detail - Psychomotor agitation
Please, specify: Psychomotor agitation
Categorical
Depression and mania (CHRIS baseline)
x0np28a
D3f detail - Increase in activity
Please, specify: Increase in activity
Categorical
Depression and mania (CHRIS baseline)
x0np28
D3f - active/physically restless
During the times when you felt high, full of energy, or irritable did you:) Become so active or physically restless that others were worried about you?
Categorical
Depression and mania (CHRIS baseline)
x0np27
D3e - easily distracted
(During the times when you felt high, full of energy, or irritable did you:) Become easily distracted so that any little interruption could distract you?
Categorical
Depression and mania (CHRIS baseline)
x0np26
D3d - have racing thoughts
(During the times when you felt high, full of energy, or irritable did you:) Have racing thoughts?
Categorical
Depression and mania (CHRIS baseline)
x0np25
D3c - walk fast/without stopping
(During the times when you felt high, full of energy, or irritable did you:) Talk too much without stopping, or so fast that people had difficulty understanding?
Categorical
Depression and mania (CHRIS baseline)
x0np24
D3b - need less sleep
(During the times when you felt high, full of energy, or irritable did you:) Need less sleep (for example, feel rested after only a few hours sleep)?
Categorical
Depression and mania (CHRIS baseline)
x0np23
D3a - do that others couldn't do
During the times when you felt high, full of energy, or irritable did you: Feel that you could do things others couldn’t do, or that you were an especially important person?
Categorical
Depression and mania (CHRIS baseline)
x0np22
D2 - persistently irritable
Have you ever been persistently irritable, for several days, so that you had arguments or verbal or physical fights, or shouted at people outside your family? Have you or others noticed that you have been more irritable or over reacted, compared to other people, even in situations that you felt were justified?
Categorical
Depression and mania (CHRIS baseline)
x0np21
D1 - feel up/high
Have you ever had a period of time when you were feeling ‘up’ or ‘high’ or ‘hyper’ or so full of energy or full of yourself that you got into trouble, or that other people thought you were not your usual self? Do not consider times when you were intoxicated on drugs or alcohol.
Categorical
Depression and mania (CHRIS baseline)
x0np00
Consent M.I.N.I. (y/n)
Informed consent neuropsychiatric interview
Categorical
Depression and mania (CHRIS baseline)
x0np14
Age at onset - depression
How old were you when your first depressive episode started?
Integer
Depression and mania (CHRIS baseline)
x0np13
A6 - frequency
How many episodes of depression did you have in your lifetime?
Integer
Depression and mania (CHRIS baseline)
x0np12
A5a - 2 months distance (y/n)
In between 2 episodes of depression, did you ever have an interval of at least 2 months, without any depression and any loss of interest?
Categorical
Depression and mania (CHRIS baseline)
x0np11
A5 - recurrence (y/n)
During your lifetime, did you have other episodes of two weeks or more when you felt depressed or uninterested in most things, and had most of the problems we just talked about?
Categorical
Depression and mania (CHRIS baseline)
x0np10
A4 - social problems (y/n)
Did these symptoms cause significant problems at home, at work, socially, or at school, or were you hospitalized for these problems?
Categorical
Depression and mania (CHRIS baseline)
x0np09
A3g - suicidal thoughts
(Over these two weeks, when you felt depressed or uninterested:) Did you repeatedly consider hurting yourself, feel suicidal, or wish that you were dead?
Categorical
Depression and mania (CHRIS baseline)
x0np09a
A3f detail - thoughts of death
Please, specify: Thoughts of death
Categorical
Depression and mania (CHRIS baseline)
x0np09b
A3f detail - suicidal ideation
Please, specify: Suicidal ideation
Categorical
Depression and mania (CHRIS baseline)
x0np09c
A3f detail - specific plan for committing suicide
Please, specify: Specific plan for committing suicide
Categorical
Depression and mania (CHRIS baseline)
x0np08b
A3f detail - indecisiveness
Please, specify: Indecisiveness
Categorical
Depression and mania (CHRIS baseline)
x0np08a
A3f detail - diminished ability to think
Please, specify: Diminished ability to think
Categorical
Depression and mania (CHRIS baseline)
x0np09d
A3f detail - Suicide attempt
Please, specify: Suicide attempt
Categorical
Depression and mania (CHRIS baseline)
x0np08
A3f - difficulty concentrating
(Over these two weeks, when you felt depressed or uninterested:) Did you have difficulty concentrating or making decisions almost every day?
Categorical
Depression and mania (CHRIS baseline)
x0np07a
A3e detail - worthlessness
Please, specify: Worthlessness
Categorical
Depression and mania (CHRIS baseline)
x0np07b
A3e detail - inappropriate guilt
Please, specify: Inappropriate guilt
Categorical
Depression and mania (CHRIS baseline)
x0np07
A3e - feel worthless/guilty
(Over these two weeks, when you felt depressed or uninterested:) Did you feel worthless or guilty almost every day?
Categorical
Depression and mania (CHRIS baseline)
x0np06
A3d - feel tired
(Over these two weeks, when you felt depressed or uninterested:) Did you feel tired or without energy almost every day?
Categorical
Depression and mania (CHRIS baseline)
x0np05b
A3c detail - psychomotor retardation
Please, specify: Psychomotor retardation
Categorical
Depression and mania (CHRIS baseline)
x0np05a
A3c detail - psychomotor agitation
Please, specify: Psychomotor agitation
Categorical
Depression and mania (CHRIS baseline)
x0np05
A3c - psychomotor changes
(Over these two weeks, when you felt depressed or uninterested:) Did you talk or move more slowly than normal or were you fidgety, restless or having trouble sitting still almost every day?
Categorical
Depression and mania (CHRIS baseline)
x0np04b
A3b detail - waking up in the middle of the night
Please, specify: Waking up in the middle of the night
Categorical
Depression and mania (CHRIS baseline)
x0np04d
A3b detail - excessive sleep
Please, specify: Excessive sleep
Categorical
Depression and mania (CHRIS baseline)
x0np04c
A3b detail - early morning awakening
Please, specify: Early morning awakening
Categorical
Previous
1
32
33
34
35
36
43
Next